Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001963781 | SCV002255191 | likely benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-09-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004970659 | SCV005536050 | uncertain significance | Inborn genetic diseases | 2024-09-09 | criteria provided, single submitter | clinical testing | The c.254T>A (p.I85N) alteration is located in exon 5 (coding exon 5) of the ATRX gene. This alteration results from a T to A substitution at nucleotide position 254, causing the isoleucine (I) at amino acid position 85 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |